🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

18 recruiting trials

for Cancer-associated Thrombosis

A Study of Cardiac Magnetic Resonance Imaging (CMR) for Evaluating Catheter-Associated Right Atrial Clot in People With Cancer NCT07549477NA7 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Cardiac MRI Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers NCT07493304Phase 313 sites📍 Hialeah📍 New York📍 El Paso Regeneron Pharmaceuticals · Tests: REGN7508, Apixaban Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus NCT05969496Phase 23 sites📍 Aurora📍 Highlands Ranch📍 Lone Tree University of Colorado, Denver · Tests: Axitinib, Pembrolizumab Thrombin Generation Parameters and Bleeding in Patients Treated With Anticoagulants for Cancer Associated Thrombosis NCT06386107NA4 sites📍 Clermont-Ferrand📍 Grenoble📍 Lyon Centre Hospitalier Universitaire de Saint Etienne · Tests: Thrombin Generation Assay (TGA) Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies NCT07270263NA1 site📍 Gdansk Medical University of Gdansk · Tests: Apixaban, Rivaroxaban, low molecular weight heparin (enoxaparin sodium) REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis NCT07410117Phase 323 sites📍 Hialeah📍 North Miami Beach📍 New York Regeneron Pharmaceuticals · Tests: REGN7508, Placebo Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism NCT07399977NA8 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: MSK-ACCESS, ctDNA/VTE Risk Score: Registry of Thrombosis & NEoplasia of "Sociedad Española de Oncología Médica" NCT03855592n/a48 sites📍 Alcoy📍 Elche📍 Palma Fundación Sociedad Española de Oncologia Médica TIPS Plus Half-dose Donafenib in AHCC with PVTT-associated Portal Hypertension NCT06646198Phase 21 site📍 Guangzhou Fei Gao · Tests: Transjugular intrahepatic portosystemic shunt (TIPS), Donafenib TIPS Plus Cadonilimab in Advanced HCC with Tumor Thrombosis-associated Portal Hypertension:a Prospective, Single-arm, Phase II Study NCT05882370Phase 21 site📍 Guangzhou Fei Gao · Tests: Cadonilimab, transjugular intrahepatic portosystemic shunt (TIPS) Prospective Evaluation of the Treatment of Cancer Associated Superficial Venous NCT07210671n/a1 site📍 Amiens Centre Hospitalier Universitaire, Amiens Immune Checkpoint Inhibitor Associated Cardiovascular Adverse Events in Patients With Cancer NCT06519292n/a1 site📍 Amsterdam Hanneke W. M. van Laarhoven · Tests: Coronary computed tomography angiography (CCTA) at baseline, Coronary computed tomography angiography (CCTA) after 1 ye… STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis NCT05255003Phase 44 sites📍 Edmonton📍 Ottawa📍 Saint Catharines Tzu-Fei Wang · Tests: Enoxaparin, Dalteparin, Tinzaparin Statins to Prevent Cancer Associated Blood Clots NCT07303816Phase 49 sites📍 Irvine📍 New Haven📍 Miami Brigham and Women's Hospital · Tests: Rosuvastatin, Placebo Drug Neoadjuvant IMRT Combined With Camrelizumab and Apatinib for Resectable HCC With PVTT NCT06349317Phase 21 site📍 Fuzhou Yongyi Zeng · Tests: Neoadjuvant intensity-modulated radiotherapy combined with perioperative camrelizumab and apatinib The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer NCT06861088Phase 33 sites📍 Ventura📍 Miami Lakes📍 Boston Quercis Pharma AG · Tests: Kinisoquin™, Placebo Thromboembolic and Hemorrhagic Complications of Anticoagulant Treatment in Patients With CAT NCT06714734n/a2 sites📍 Bologna📍 Reggio Emilia IRCCS Azienda Ospedaliero-Universitaria di Bologna Development of a Risk Stratification Score for Recurrent Venous Thromboembolism and Treatment-related Clinically Relevant Bleeding in Patients With Cancer-associated Thrombosis NCT06894576n/a1 site📍 Ottawa Ottawa Hospital Research Institute
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy